Integra LifeSciences Holdings Return on Tangible Equity 2010-2024 | IART
Current and historical return on tangible equity values for Integra LifeSciences Holdings (IART) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Integra LifeSciences Holdings Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.01B | $-0.80B | 0.93% |
| 2024-06-30 | $0.02B | $-0.79B | -4.15% |
| 2024-03-31 | $0.04B | $-0.47B | -8.09% |
| 2023-12-31 | $0.07B | $-0.54B | -13.48% |
| 2023-09-30 | $0.10B | $-0.52B | -22.05% |
| 2023-06-30 | $0.13B | $-0.45B | -32.81% |
| 2023-03-31 | $0.17B | $-0.48B | -44.24% |
| 2022-12-31 | $0.18B | $-0.36B | -45.36% |
| 2022-09-30 | $0.17B | $-0.31B | -40.49% |
| 2022-06-30 | $0.17B | $-0.41B | -34.26% |
| 2022-03-31 | $0.16B | $-0.52B | -29.08% |
| 2021-12-31 | $0.17B | $-0.47B | -29.17% |
| 2021-09-30 | $0.22B | $-0.54B | -38.62% |
| 2021-06-30 | $0.21B | $-0.62B | -37.34% |
| 2021-03-31 | $0.17B | $-0.67B | -31.16% |
| 2020-12-31 | $0.13B | $-0.41B | -25.14% |
| 2020-09-30 | $0.06B | $-0.50B | -9.76% |
| 2020-06-30 | $-0.00B | $-0.61B | 0.67% |
| 2020-03-31 | $0.03B | $-0.62B | -4.44% |
| 2019-12-31 | $0.05B | $-0.57B | -8.69% |
| 2019-09-30 | $0.06B | $-0.60B | -10.16% |
| 2019-06-30 | $0.10B | $-0.55B | -16.69% |
| 2019-03-31 | $0.08B | $-0.58B | -12.71% |
| 2018-12-31 | $0.06B | $-0.63B | -7.77% |
| 2018-09-30 | $0.08B | $-0.66B | -8.79% |
| 2018-06-30 | $0.07B | $-0.71B | -8.51% |
| 2018-03-31 | $0.07B | $-1.09B | -9.59% |
| 2017-12-31 | $0.06B | $-1.14B | -11.83% |
| 2017-09-30 | $0.05B | $-0.31B | -15.23% |
| 2017-06-30 | $0.07B | $-0.34B | -21.35% |
| 2017-03-31 | $0.07B | $-0.38B | -22.69% |
| 2016-12-31 | $0.07B | $-0.23B | -26.06% |
| 2016-09-30 | $0.06B | $-0.27B | -19.23% |
| 2016-06-30 | $0.01B | $-0.30B | -2.60% |
| 2016-03-31 | $0.00B | $-0.34B | -0.34% |
| 2015-12-31 | $-0.00B | $-0.37B | 1.69% |
| 2015-09-30 | $-0.00B | $-0.38B | 1.22% |
| 2015-06-30 | $0.04B | $-0.09B | -45.71% |
| 2015-03-31 | $0.04B | $-0.11B | -45.45% |
| 2014-12-31 | $0.03B | $-0.07B | -38.20% |
| 2014-09-30 | $0.03B | $-0.08B | -190.77% |
| 2014-06-30 | $-0.01B | $-0.09B | -59.02% |
| 2014-03-31 | $-0.01B | $-0.12B | -28.92% |
| 2013-12-31 | $-0.02B | $0.22B | -27.68% |
| 2013-09-30 | $-0.02B | $0.05B | -103.70% |
| 2013-06-30 | $0.02B | $0.02B | 179.59% |
| 2013-03-31 | $0.03B | $0.01B | 504.35% |
| 2012-12-31 | $0.04B | $0.01B | 4842270319348756480.00% |
| 2012-09-30 | $0.03B | $0.02B | -283.33% |
| 2012-06-30 | $0.03B | $-0.01B | -126.73% |
| 2012-03-31 | $0.02B | $-0.02B | -107.87% |
| 2011-12-31 | $0.03B | $-0.04B | -5600.00% |
| 2011-09-30 | $0.04B | $-0.04B | 215.38% |
| 2011-06-30 | $0.05B | $0.00B | 150.40% |
| 2011-03-31 | $0.06B | $0.07B | 189.15% |
| 2010-12-31 | $0.07B | $0.04B | 481.48% |
| 2010-09-30 | $0.06B | $0.01B | -1458.82% |
| 2010-06-30 | $0.06B | $0.01B | -315.79% |
| 2010-03-31 | $0.06B | $-0.01B | -205.50% |
| 2009-12-31 | $0.05B | $-0.03B | -129.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.820B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $196.322B | 23.95 |
| Intuitive Surgical (ISRG) | United States | $195.140B | 102.02 |
| Alcon (ALC) | Switzerland | $42.414B | 28.38 |
| Edwards Lifesciences (EW) | United States | $41.569B | 26.40 |
| IQVIA Holdings (IQV) | United States | $36.630B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $34.166B | 40.24 |
| DexCom (DXCM) | United States | $28.447B | 42.84 |
| Waters (WAT) | United States | $22.175B | 32.79 |
| STERIS (STE) | Ireland | $21.157B | 24.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.795B | 0.00 |
| Hologic (HOLX) | United States | $18.343B | 19.35 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.004B | 13.35 |
| Sysmex ADR (SSMXY) | Japan | $12.946B | 0.00 |
| Globus Medical (GMED) | United States | $11.536B | 29.21 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.260B | 44.81 |
| Teleflex (TFX) | United States | $8.904B | 14.20 |
| Glaukos (GKOS) | United States | $7.940B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.884B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.632B | 26.26 |
| Veracyte (VCYT) | United States | $3.068B | 92.07 |
| Inari Medical (NARI) | United States | $2.907B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.787B | 16.09 |
| TransMedics (TMDX) | United States | $2.552B | 80.89 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 17.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.023B | 0.00 |
| RxSight (RXST) | United States | $1.807B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.427B | 0.00 |
| Artivion (AORT) | United States | $1.185B | 78.53 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.078B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 14.53 |
| Paragon 28 (FNA) | United States | $0.841B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.723B | 0.00 |
| IRadimed (IRMD) | United States | $0.675B | 36.46 |
| OrthoPediatrics (KIDS) | United States | $0.638B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.593B | 13.97 |
| AxoGen (AXGN) | United States | $0.587B | 0.00 |
| SiBone (SIBN) | United States | $0.527B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.488B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.463B | 31.05 |
| Tactile Systems Technology (TCMD) | United States | $0.428B | 23.18 |
| CVRx (CVRX) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.326B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.312B | 0.00 |
| NeuroPace (NPCE) | United States | $0.290B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.278B | 0.00 |
| Inogen (INGN) | United States | $0.223B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.194B | 0.00 |
| Nevro (NVRO) | United States | $0.169B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.153B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.146B | 15.60 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.068B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Envoy Medical (COCH) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Spectral AI (MDAI) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |